An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Clinical trial NCT04720157 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04720157
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-09
- Primary completion
- 2025-01-13
- Enrollment
- 1140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.